Treatment of mice with both anti-mPD1 and anti-mCD38 resulted in a significantly increased proportion of tumor-free mice (57%), compared to control-treated mice (0%, p < 0.001) or mice treated with anti-mPD-1 alone (24%, p = 0.017) or anti-mCD38 alone (0%, p < 0.001) (Figure 5C). Here, MYH7 is linked to neoplasm.